docetaxelpembrolizumabtislelizumabsitravatinib
…patient in sitravatinib+tislelizumab arm; 13 (6.8%) patients in docetaxel arm) (figure 1). One patient randomised to sitravatinib+tisleli…
3articles mentioning drugs
55drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Sitravatinib ×
Sitravatinib
This drug is selected. Its supporting articles are shown below.
Articles mentioning Sitravatinib
3 articles · page 1 of 1sitravatinibtislelizumabdocetaxel
…xel arm. Grade 5 haemoptysis occurred in 3 (1.6%) patients with sitravatinib plus tislelizumab. The study was terminated due to an unfavoura…
bemcentinibdabrafenibtrametinibpembrolizumaberlotinibnivolumabdocetaxelsitravatinibDMSOBGB324+1 more
…suggesting that DC inclusion dampens the macrophage response to bemcentinib.9 Separation of macrophages by A375 state was further reflected…